Total Payments
$2,040
2024 Payments
$445.12
Companies
13
Transactions
221
Medicare Patients
419
Medicare Billing
$29,508
Payment Breakdown by Category
Food & Beverage$2,040 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,040 | 221 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $694.45 | 42 | $0 (2024) |
| Allergan, Inc. | $595.49 | 121 | $0 (2020) |
| Novo Nordisk Inc | $386.42 | 33 | $0 (2024) |
| Lilly USA, LLC | $89.23 | 6 | $0 (2024) |
| MannKind Corporation | $71.59 | 5 | $0 (2018) |
| Shire North American Group Inc | $48.34 | 3 | $0 (2017) |
| Nestle HealthCare Nutrition Inc. | $43.65 | 3 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $30.08 | 2 | $0 (2023) |
| Daiichi Sankyo Inc. | $22.96 | 2 | $0 (2020) |
| Amgen Inc. | $19.17 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $445.12 | 28 | ABBVIE INC. ($195.88) |
| 2023 | $480.56 | 41 | AbbVie Inc. ($278.82) |
| 2022 | $210.12 | 10 | ABBVIE INC. ($181.86) |
| 2021 | $69.87 | 4 | AbbVie Inc. ($37.89) |
| 2020 | $56.15 | 4 | Allergan, Inc. ($33.19) |
| 2019 | $257.47 | 49 | Allergan Inc. ($228.87) |
| 2018 | $211.38 | 35 | Allergan Inc. ($137.02) |
| 2017 | $309.68 | 50 | Allergan Inc. ($196.41) |
All Payment Transactions
221 individual payment records from CMS Open Payments — Page 7 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/15/2018 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $3.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/11/2018 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/04/2018 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/28/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.17 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.81 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Diabetes | ||||||
| 03/16/2018 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: DIABETES MEDICINE | ||||||
| 03/16/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $6.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/14/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2018 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $4.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/26/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.55 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2018 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Cardiology | ||||||
| 02/23/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $2.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/10/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.86 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.86 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2018 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: DIABETES MEDICINE | ||||||
| 01/26/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/12/2018 | Allergan Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/12/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.59 | General |
| Category: NEUROSCIENCE | ||||||
| 01/05/2018 | Allergan Inc. | NAMZARIC (Drug), NAMENDA XR | Food and Beverage | In-kind items and services | $2.90 | General |
| Category: NEUROSCIENCE | ||||||
| 12/23/2017 | Allergan Inc. | VIIBRYD (Drug) | Food and Beverage | In-kind items and services | $4.38 | General |
| Category: NEUROSCIENCE | ||||||
| 12/22/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2017 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $4.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/15/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $3.25 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 33 | 34 | $5,440 | $1,156 |
| 2020 | 9 | 386 | 557 | $67,114 | $28,352 |
Total Patients
419
Total Services
591
Medicare Billing
$29,508
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 34 | $5,440 | $1,156 | 21.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 136 | 270 | $43,200 | $17,357 | 40.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 71 | 91 | $10,010 | $3,995 | 39.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 45 | 55 | $4,930 | $2,193 | 44.5% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 26 | 26 | $2,600 | $1,585 | 61.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 13 | 13 | $2,163 | $1,449 | 67.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 29 | 33 | $1,616 | $727.32 | 45.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 39 | 40 | $1,600 | $642.48 | 40.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 15 | 17 | $515.00 | $210.62 | 40.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 12 | 12 | $480.00 | $191.88 | 40.0% |
About Dr. Katherine Dumont, MD
Dr. Katherine Dumont, MD is a Family Medicine healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1730374653.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Katherine Dumont, MD has received a total of $2,040 in payments from pharmaceutical and medical device companies, with $445.12 received in 2024. These payments were reported across 221 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,040).
As a Medicare-enrolled provider, Dumont has provided services to 419 Medicare beneficiaries, totaling 591 services with total Medicare billing of $29,508. Data is available for 2 years (2020–2021), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Cincinnati, OH
- Active Since 09/13/2007
- Last Updated 10/26/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1730374653
Products in Payments
- VRAYLAR (Drug) $438.43
- UBRELVY (Drug) $319.00
- LINZESS (Drug) $171.47
- QULIPTA (Drug) $166.63
- Wegovy (Drug) $130.60
- Ozempic (Drug) $108.70
- Rybelsus (Drug) $97.99
- BYSTOLIC (Drug) $95.81
- MOUNJARO (Drug) $89.23
- AFREZZA (Drug) $71.59
- VIBERZI (Drug) $58.32
- ZENPEP (Drug) $43.65
- MYDAYIS (Drug) $34.76
- BREZTRI (Drug) $30.08
- Saxenda (Drug) $23.84
- INJECTAFER (Drug) $22.96
- NAMZARIC (Drug) $20.67
- Corlanor (Drug) $19.17
- QUVIVIQ (Drug) $13.78
- VYVANSE (Drug) $13.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cincinnati
Michael Heile, Md, MD
Family Medicine — Payments: $382,686
Family Medicine $382,686
Amy Mechley, Md, MD
Family Medicine — Payments: $277,547
Family Medicine $277,547
Paul Nugent, D.o, D.O
Family Medicine — Payments: $159,309
Family Medicine $159,309
Melissa Schroer, Md, MD
Family Medicine — Payments: $147,431
Family Medicine $147,431
Dr. Shayla Pullen, Md, MD
Family Medicine — Payments: $32,310
Family Medicine $32,310
William Cox, Md, MD
Family Medicine — Payments: $24,617
Family Medicine $24,617